Johnson & Johnson to Participate in Credit Suisse 2012 Healthcare Conference

NEW BRUNSWICK, N.J., Nov. 7, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Credit Suisse 2012 Healthcare Conference Wednesday, Nov. 14th, at the Arizona Biltmore Hotel, 2400 E. Missouri Avenue, Phoenix, AZ.   Dominic Caruso, Vice President, Finance & Chief Financial Officer, will represent the company in a session scheduled at 11:00 a.m. (Mountain Standard Time).

This broadcast will be available to interested investors and parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available shortly after the live webcast.

SOURCE Johnson & Johnson

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.